Jeffrey B. Landau, Chief Business Officer: CytomX Therapeutics CTMX Sell · Filed 24/03/21

Trade details

Type: Insider sale
Amount: $13,714.58
Shares · price: 6,562 sh · $2.09 a share
Held after: 110,060 sh
Stock: CytomX Therapeutics CTMX
Person: Jeffrey B. LandauChief Business Officer
Trade date: 24/03/19
Filed: 24/03/21
Days to filing: 2 days

Sold 5.6% of holdings

Share of holding sold: 5.6%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/18~24/04/18

Jeffrey B. Landau's recent trades

Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20
Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,355
4,119 sh
$5,355
Filed 23/09/22
Traded 23/09/22
Jeffrey B. LandauCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$2,924
1,477 sh
$2,924
Filed 23/03/20
Traded 23/03/16

Jeffrey B. Landau, Chief Officer — sold $13.7K of CytomX Therapeutics CTMX · 5.6% of holdings | Whalegun